Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial

The Lancet - Tập 384 Số 9937 - Trang 37-44 - 2014
Nicola Longo1, Cary O. Harding2, Barbara K. Burton3, Dorothy K. Grange4, Jerry Vockley5, Melissa P. Wasserstein6, Gregory M. Rice7, Alejandro Dorenbaum8, Jutta K. Neuenburg8, Donald G. Musson8, Zhonghua Gu8, Saba Sile8
1University of Utah, Salt Lake City, UT, USA. Electronic address: [email protected].
2Oregon Health Sciences University, Portland, OR, USA
3Ann and Robert H. Lurie Children's Hospital and Northwestern University Feinberg School of Medicine, Chicago, IL, USA
4Washington University School of Medicine. St. Louis, Mo. USA
5University of Pittsburgh School of Medicine, PA, USA
6Mount Sinai School of Medicine, New York, NY USA
7University Of Wisconsin, Madison, WI USA
8BioMarin Pharmaceutical, Novato, CA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Scriver, 2001, Hyperphenylalaninemia: phenylalanine hydroxylase deficiency, 1667

Mitchell, 2011, Phenylalanine hydroxylase deficiency, Genet Med, 13, 697, 10.1097/GIM.0b013e3182141b48

Ozalp, 1990, Inherited metabolic disorders in Turkey, J Inherit Metab Dis, 13, 732, 10.1007/BF01799576

DiLella, 1986, Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene, Biochemistry, 25, 743, 10.1021/bi00352a001

Aoki, 2003, Long term follow-up of patients with inborn errors of metabolism detected by the newborn screening program in Japan, Southeast Asian J Trop Med Public Health, 34, 19

2001, National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16–18, 2000, Pediatrics, 108, 972, 10.1542/peds.108.4.972

Fisch, 2000, Comments on diet and compliance in phenylketonuria, Eur J Pediatr, 159, S142, 10.1007/PL00014378

Walter, 2002, How practical are recommendations for dietary control in phenylketonuria?, Lancet, 360, 55, 10.1016/S0140-6736(02)09334-0

Azen, 1996, Summary of findings from the United States Collaborative Study of children treated for phenylketonuria, Eur J Pediatr, 155, S29, 10.1007/BF03036507

White, 2001, Deficits in memory strategy use related to prefrontal dysfunction during early development: evidence from children with phenylketonuria, Neuropsychology, 15, 221, 10.1037/0894-4105.15.2.221

White, 2002, Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria, J Int Neuropsychol Soc, 8, 1, 10.1017/S1355617702811018

Leuzzi, 2004, Executive function impairment in early-treated PKU subjects with normal mental development, J Inherit Metab Dis, 27, 115, 10.1023/B:BOLI.0000028781.94251.1f

Feldmann, 2005, Frontal lobe-dependent functions in treated phenylketonuria: blood phenylalanine concentrations and long-term deficits in adolescents and young adults, J Inherit Metab Dis, 28, 445, 10.1007/s10545-005-0445-7

Gassió, 2005, School performance in early and continuously treated phenylketonuria, Pediatr Neurol, 33, 267, 10.1016/j.pediatrneurol.2005.05.003

Sarkissian, 2008, Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria, Proc Natl Acad Sci USA, 105, 20894, 10.1073/pnas.0808421105

Gregory, 2007, Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods, Genet Med, 9, 761, 10.1097/GIM.0b013e318159a355